Programmed Cell Death Protein-1 (PD-1) Monoclonal Antibody for EBV-HLH and CAEBV as First-line Therapy
Clinical trial NCT05039580 · UNKNOWN
Trial details
- NCT number
- NCT05039580
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-15
- Primary completion
- 2023-04-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.